Lu AA24530 shows positive results in major depressive disorder phase ... - Phramalive.com

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service15 times read : Adjust font size: Decrease font Enlarge font
image

COPENHAGEN, July 2, 2009--H. Lundbeck A/S (Lundbeck) today announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD). The primary objective of the study ...

Read this article...



Post your comment comment Comments (0 posted)

More News

copyright